Genomic Modeling as an Approach to Identify Surrogates for Use in Experimental Validation of SARS-CoV-2 and HuNoV Inactivation by UV-C Treatment by Pendyala, Brahmaiah et al.
Tennessee State University 
Digital Scholarship @ Tennessee State University 
Agricultural and Environmental Sciences 
Faculty Research 
Department of Agricultural and Environmental 
Sciences 
9-29-2020 
Genomic Modeling as an Approach to Identify Surrogates for Use 
in Experimental Validation of SARS-CoV-2 and HuNoV Inactivation 
by UV-C Treatment 
Brahmaiah Pendyala 
Tennessee State University 
Ankit Patras 
Tennessee State University 
Bharat Pokharel 
Tennessee State University 
Doris D’Souza 
University of Tennessee, Knoxville 
Follow this and additional works at: https://digitalscholarship.tnstate.edu/agricultural-and-environmental-
sciences-faculty 
 Part of the Genetics Commons, and the Immunology and Infectious Disease Commons 
Recommended Citation 
Pendyala B, Patras A, Pokharel B and D’Souza D (2020) Genomic Modeling as an Approach to Identify 
Surrogates for Use in Experimental Validation of SARS-CoV-2 and HuNoV Inactivation by UV-C Treatment. 
Front. Microbiol. 11:572331. doi: 10.3389/fmicb.2020.572331 
This Article is brought to you for free and open access by the Department of Agricultural and Environmental 
Sciences at Digital Scholarship @ Tennessee State University. It has been accepted for inclusion in Agricultural and 
Environmental Sciences Faculty Research by an authorized administrator of Digital Scholarship @ Tennessee State 
University. For more information, please contact XGE@Tnstate.edu. 
fmicb-11-572331 September 25, 2020 Time: 20:3 # 1
ORIGINAL RESEARCH
published: 29 September 2020
doi: 10.3389/fmicb.2020.572331
Edited by:
Mirian A. F. Hayashi,
Federal University of São Paulo, Brazil
Reviewed by:
Anca Ioana Nicolau,
Dunarea de Jos University, Romania
Kalmia Kniel,







This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 13 June 2020
Accepted: 08 September 2020
Published: 29 September 2020
Citation:
Pendyala B, Patras A, Pokharel B
and D’Souza D (2020) Genomic
Modeling as an Approach to Identify
Surrogates for Use in Experimental
Validation of SARS-CoV-2 and HuNoV
Inactivation by UV-C Treatment.
Front. Microbiol. 11:572331.
doi: 10.3389/fmicb.2020.572331
Genomic Modeling as an Approach
to Identify Surrogates for Use in
Experimental Validation of
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1 Department of Agricultural and Environmental Sciences, Food Science Program, College of Agriculture, Tennessee State
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United States
Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) is responsible for
the COVID-19 pandemic that continues to pose significant public health concerns.
While research to deliver vaccines and antivirals are being pursued, various effective
technologies to control its environmental spread are also being targeted. Ultraviolet light
(UV-C) technologies are effective against a broad spectrum of microorganisms when
used even on large surface areas. In this study, we developed a pyrimidine dinucleotide
frequency based genomic model to predict the sensitivity of select enveloped and non-
enveloped viruses to UV-C treatments in order to identify potential SARS-CoV-2 and
human norovirus surrogates. The results revealed that this model was best fitted using
linear regression with r2 = 0.90. The predicted UV-C sensitivity (D90 – dose for 90%
inactivation) for SARS-CoV-2 and MERS-CoV was found to be 21.5 and 28 J/m2,
respectively (with an estimated 18 J/m2 obtained from published experimental data
for SARS-CoV-1), suggesting that coronaviruses are highly sensitive to UV-C light
compared to other ssRNA viruses used in this modeling study. Murine hepatitis virus
(MHV) A59 strain with a D90 of 21 J/m2 close to that of SARS-CoV-2 was identified as a
suitable surrogate to validate SARS-CoV-2 inactivation by UV-C treatment. Furthermore,
the non-enveloped human noroviruses (HuNoVs), had predicted D90 values of 69.1, 89,
and 77.6 J/m2 for genogroups GI, GII, and GIV, respectively. Murine norovirus (MNV-1)
of GV with a D90 = 100 J/m2 was identified as a potential conservative surrogate for UV-
C inactivation of these HuNoVs. This study provides useful insights for the identification
of potential non-pathogenic (to humans) surrogates to understand inactivation kinetics
and their use in experimental validation of UV-C disinfection systems. This approach can
be used to narrow the number of surrogates used in testing UV-C inactivation of other
human and animal ssRNA viral pathogens for experimental validation that can save cost,
labor and time.
Keywords: genomic modeling, UV-C inactivation, viruses, SARS-CoV-2 (2019-nCoV), norovirus (NoV), surrogates
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INTRODUCTION
Coronaviruses belong to the family of Coronaviridae, comprising
of 26 to 30 kb, positive-sense, single-stranded RNA, in
an enveloped capsid (Woo et al., 2010). Coronaviruses can
cause severe infectious diseases in human and vertebrates,
being fatal in some cases. Severe acute respiratory syndrome
(SARS) coronavirus (SARS-CoV-1), a β-coronavirus emerged
in Guangdong, southern China, in November, 2002 (Guan
et al., 2003), and the Middle East respiratory syndrome (MERS)
coronavirus (MERS-CoV), was first detected in Saudi Arabia
in 2012 (Alagaili et al., 2014). Since late December 2019, a
novel β-coronavirus (2019-nCoV or SARS-CoV-2) has been
responsible for the pandemic coronavirus disease (COVID-19)
with >7.2 million confirmed cases throughout the world, and a
fatality rate of approximately 5.7% as of 11 June, 2020 (World
Health Organization [WHO], 2020a). This 2019-nCoV is thought
to have originated from a seafood market of Wuhan city, Hubei
province, China, and has spread rapidly to other provinces of
China and other countries (Zhu et al., 2020).
According to current evidence documented by the World
Health Organization [WHO] (2020a,b), SARS-CoV-2 virus
(2019-nCoV) is transmitted between humans through
respiratory droplets and contact (person-to-person, fomites,
etc.) routes (World Health Organization [WHO], 2020b). van
Doremalen et al. (2020) reported that SARS-CoV-2 remained
viable in aerosols throughout the 3 h duration of the experiment
and more stable on plastic and stainless steel than on copper and
cardboard, and virus was detected up to 72 h after the application
to these surfaces at 21–23◦C and 40% relative humidity. Given
the ability of these viruses to survive in the environment,
appropriate treatment strategies are needed to inactivate SARS-
CoV-2. As per WHO recommendations, SARS-CoV-2 may be
inactivated using chemical disinfectants. As of 07 April, 2020, the
United States Environmental Protection Agency [USEPA] (2020)
has announced a list of 428 registered chemical disinfectants that
have been approved for use against SARS-CoV-2 (United States
Environmental Protection Agency [USEPA], 2020). On the
other hand, physical disinfection method “ultraviolet light
(UV) treatment” (with germicidal UV-C at wavelengths from
100 to 280 nm) can be an effective approach to inactivate
SARS-CoV-2 on surface areas and in the air. UV inactivates a
broad spectrum of microorganisms by damaging the DNA or
RNA and thereby prevents and/or alters cellular functions and
replication (Patras et al., 2020). UV-C inactivation of various
microorganisms such as pathogenic bacteria, spores, protozoa,
algae and viruses has been reported (Malayeri et al., 2016;
Bhullar et al., 2019; Gopisetty et al., 2019; Pendyala et al., 2019,
2020; Patras et al., 2020). Because UV inactivation studies with
SARS-CoV-2 requires specifically trained and skilled personnel
working under biosafety level 3 (BSL-3) laboratory containment
conditions, the use of surrogate coronaviruses has the potential
to cross these hurdles for experimental validation of designed
UV systems. Based on the biophysical properties and genomic
structure, literature studies on testing the efficacy of disinfectants
against coronaviruses used the following surrogates; murine
hepatitis virus (MHV), Human coronavirus 229 E, transmissible
gastroenteritis virus (TGEV), and feline infectious peritonitis
virus (FIPV) (Kumar et al., 2020). However, the selection of
potential surrogates to SARS-CoV-2 requires a comparative
evaluation of UV-C sensitivity between these viruses. As of date,
the precise experimental UV-C susceptibility (D90 value) of
SARS-CoV/SARS-CoV-2 is not reported.
Human noroviruses (HuNoVs) cause >80% of global
non-bacterial gastroenteritis that can be spread through
contamination of food, water, fomites, or direct contact, and
also via aerosolization (Fankhauser et al., 2002; Widdowson
et al., 2005; Godoy et al., 2006). HuNoVs are also single-stranded
RNA viruses that are small 27 to 32 nM in size that belong to
the Caliciviridae family. However, HuNoVs are enclosed in a
non-enveloped capsid, unlike SARS-CoV-2 that is enveloped.
UV-C inactivation data on the HuNoV genogroups is limited
due to the lack of available cultivation methods to obtain high
infectious titers (Doultree et al., 1999; Ettayebi et al., 2016; Estes
et al., 2019). Thus, reverse transcription quantitative polymerase
chain reaction (RT-qPCR) is widely used for assessing survivor
populations of HuNoVs after treatment. However, research
studies showed overestimation of survivors with RT-qPCR
in comparison to virus infectivity plaque assays (Rönnqvist
et al., 2014; Wang and Tian, 2013; Walker et al., 2019). As an
alternative, cultivable animal viruses [caliciviruses, echoviruses
and murine norovirus (MNV)] have been used as surrogates to
determine UV-C inactivation of HuNoVs (Thurston-Enriquez
et al., 2003; de Roda Husman et al., 2004; Lee et al., 2008; Park
et al., 2011), but proper selection of surrogates which mimic
the UV-C inactivation characteristics of HuNoVs is required to
evaluate kinetics and scale up validation studies.
Furthermore, it is well known that microorganisms respond
to UV exposure at rates defined in terms of UV rate constants
(Patras et al., 2020). The slope of the logarithmic decay curve
is defined by the rate constant, which is designated as k. The
UV rate constant k has units of cm2/mJ or m2/J and is also
known as the UV susceptibility. It can be also defined as D90 or
D10 [dose for 90% inactivation or 10% survival] as the primary
indicator of UV susceptibility. UV dose is expressed as J/m2
or mJ/cm2 (Patras et al., 2020). The varied microbial sensitivity
to ultraviolet light (UV) among species of microbes, is due
to several intrinsic factors including physical size, presence of
chromophores or UV absorbers, presence of repair enzymes or
dark/light repair mechanisms, hydrophilic surface properties,
relative index of refraction, specific UV spectrum (broad band
UVC/UVB versus narrow band UVC), genome based parameters;
molecular weight of nucleic acids, DNA conformation (A or B),
G+C%, and % of potential pyrimidine or purine dimerization
(Kowalski et al., 2009).
The physical size of a virus bears no clear relationship with
UV susceptibility, except that for the largest viruses, as size
increases, the UV rate constant tends to decrease slightly (which
is likely the result of UV scattering) (Kowalski et al., 2009).
There is no thorough literature available on the above-mentioned
optical parameters, hydrophilic surface properties and repair
mechanisms relating to UV sensitivity. On the other hand,
genome sequences of UV susceptibility can be easily retrieved
from genome databases and the development of genomic models
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based on the above mentioned genome-based parameters is
feasible to predict the UV susceptibility of ssRNA viruses, which
include human pathogenic novel viruses (such as SARS-CoV-2)
and cultivation-challenging HuNoVs.
Our hypothesis is that predicting UV-C inactivation based on
genomic modeling, will enable the determination of surrogates
to be used in UV-C validation studies. In the present study, we
attempted to develop a genomic model to predict and compare
the UV sensitivity of enveloped SARS-CoV-2 and non-enveloped
HuNoVs and to determine their suitable surrogates for use in
UV-C process validation.
MATERIALS AND METHODS
Collection of Reported ssRNA Viruses
UV254 Sensitivity (D90 Values)
We collected UV-C sensitivity of ssRNA viruses form published
studies and carefully selected D90 values (Table 1). The selection
was based on the careful assessment of methods that were used to
determine UV-C sensitivity. The selected UV-C sensitivity of an




Murine sarcoma virus 190 Kelloff et al., 1970; Nomura et al., 1972
Bacteriophage MS2 183a Malayeri et al., 2016
Moloney murine
leukemia virus
115 Nomura et al., 1972
Murine norovirus 100 Lee et al., 2008; Park et al., 2011
Coxsackievirus 79 Battigelli et al., 1993; Gerba et al., 2002;
Shin et al., 2005
Human parechovirus 75 Gerba et al., 2002
Polio virus 73 Gerba et al., 2002;
Thompson et al., 2003;
Lazarova and Savoye, 2004;
Shin et al., 2005;
Simonet and Gantzer, 2006
Canine calicivirus (CCV) 67 de Roda Husman et al., 2004
Feline calicivirus (FCV) 60 Thurston-Enriquez et al., 2003;
de Roda Husman et al., 2004;
Park et al., 2011
Sindbis virus 55 Zavadova and Libikova, 1975;
von Brodorotti and Mahnel, 1982
Venezuelan equine
encephalitis virus
55 Smirnov et al., 1992
Western equine
encephalomyelitis virus
54 Dubinin et al., 1975
Hepatitis A virus 51 Wilson et al., 1992; Battigelli et al., 1993;
Wiedenmann et al., 1993
Semliki forest virus 25 Weiss and Horzinek, 1986
Measles virus 22 Stefano et al., 1976
SARS-CoV-1 18b Kariwa et al., 2006
Average D90 values refer average of reference source studies.
aAverage value of all (45) MS2 reports.
bEstimated value from initial linear kinetics of data and considering 90% of light
transmission through test fluid.
ssRNA virus is determined via the standard method (Bolton and
Linden, 2003), with the log10 survivors as a function of UV dose
and represented as D90.
Determination of Genomic Parameters;
Genome Size, and Pyrimidine
Dinucleotide Frequency Value (PyNNFV)
The molecular size and nucleotide sequences of genomes
used in this study were directly obtained from available
NCBI genome database (Table 2 and Table 5). PyNNFV
model was developed based on the frequency of each type
of pyrimidine dinucleotides (TT, TC, CT, and CC) which
varies based on genome sequences. Pyrimidines are almost
10 times more susceptible to photoreaction (Smithyman and
Hanawalt, 1969), while strand breaks, inter-strand cross links
and DNA-protein cross links form with less frequency (1:1000
of the number of dimers and hydrates) (Setlow and Carrier,
1966). Three simple rules were formulated for sequence-
dependent dimerization (Becker and Wang, 1989); “(i) When
two or more pyrimidines are neighboring to one another,
photoreactions are observed at both pyrimidines, (ii) Non-
adjacent pyrimidines exhibit little or no photoreactivity, and
(iii) Purines form UV photoproducts when they are flanked at
5′ side by two or more adjacent pyrimidine residues.” Therefore,
we considered 100% probability of formation of photoreaction
products when PyNN are flanked by pyrimidines on both
sides and 50% probability when PyNN are flanked by purine
on either side. The individual PyNNs were counted by the
exclusive method (each pyrimidine considered in one PyNN
combination only). Research studies showed the proportion of
photoreaction products in the order of TT > TC > CT > CC
(Douki, 2013), thus same sequence was followed in counting
individual PyNNs. Table 3 shows the method used for PyNNFV
calculation in this study. A mathematical function was written
to calculate PyNNFV from the potential PyNNs to exist in the





The PyNNFVs from complete genome sequences of 16 ssRNA
viruses and corresponding reported D90 values were used to plot
a model graph. Then, the correlation between PyNNFVs and D90
values was analyzed by fitting the appropriate regression model
(linear regression).
RESULTS AND DISCUSSION
Table 1 shows the median D90 values collected from UV-C
inactivation studies of various ssRNA viruses. The data
was selected from the studies conducted with uniform viral
suspensions in transparent medium (water or phosphate buffer
saline), followed standard method for UV dose calculation
(Bolton and Linden, 2003). The D90 values reported for ssRNA
viruses ranged from 18 J/m2 for SARS-CoV-1 to 190 J/m2
for murine sarcoma virus. Genomic parameters; genome size,
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Bacteriophage MS2 NC_001417.2 3569 0.00804
Murine sarcoma virus NC_001502.1 5833 0.00807
Human parechovirus NC_001897.1 7348 0.00210
Murine norovirus NC_008311.1 7382 0.00570
Coxsackievirus KX595291.1 7410 0.00314
Polio virus NC_002058.3 7440 0.00263
Hepatitis A virus KP879217.1 7476 0.00209




Canine Calicivirus NC_004542.1 8513 0.00345







Sindbis virus NC_001547.1 11703 0.00149
Measles virus NC_001498.1 15894 0.00134
SARS-CoV-1 NC_004718.3 29751 0.00067
aPyrimidine dinucleotide frequency value.
PyNNFVs of respective viruses were shown in Table 2. The
values are in the range of 3569 bp to 29751 bp for genomic size;
0.00067–0.00807 for PyNNFV.
Genomic Models to Predict UV-C
Sensitivity of ssRNA Viruses
To determine the relationship between genome size and UV-C
sensitivity, the D90 values were plotted against the genome size of
various ssRNA viruses (Figure 1). The data were best fitted to log
linear regression model with r2 = 0.63. The results revealed that
there was a decisive relationship between genome size and UV
sensitivity across the range of 3569–29751 bp.
Further to evaluate the influence of base composition and
sequence along with genome size on UV-C sensitivity, the D90
values were plotted versus PyNNFV (Figure 2). Linear regression
model was best fitted with r2 = 0.90. Therefore, based on the value
of r squared a moderate positive relationship was found between
PyNNFV and UV-C sensitivity of the virus. The following
linear regression equation shows the correlation between D90
values and PyNNFV.
y = 19984x+ 10.409 (2)
Also, to predict the distribution of UV-C sensitivities and
estimates of the true population mean using this model, 95%
prediction and confidence intervals were shown in Figure 2. To
confirm the adequacy of the fitted model, studentized residuals
versus run order were tested and the residuals were observed
to be scattered randomly, suggesting that the variance was
constant. It can be indicated from Figure 3 that predicted
values were in close agreement with the experimental values
and were found to be not significantly different at p > 0.05
TABLE 3 | Calculation of PyNNFV value for SARS-CoV-2.
Parameter TT TC CT CC
PyNNsa 2454 1020 881 535
PyNNs flanked with
purinea
773 (ATT) 324 (ATC) 298 (ACT) 281 (ACC)
412 (TTA) 250 (TCA) 244 (CTA) 90 (CCA)
530 (GTT) 174 (GTC) 187 (GCT) 84 (GCC)
230 (TTG) 37 (TCG) 91 (CTG) 10 (CCG)
Total PyNNs flanked
with purine
1945 785 820 472
PyNNs flanked
without purine
509 235 61 63
Probability of each
PyNNb
1481.5 627.5 471 299
PyNNs(%)c 4.956341 2.099294 1.575725 1.000301
Genome size 29891
PyNNFV 0.000555
aValues are counted using exclusive method (once one doublet or triplet is located
in the genome, it is excluded from participating in other dimers).
bOverall probability of each PyNN is calculated by considering 50% probability
(0.5) for PyNNs flanked with purine and 100% probability (1.0) for PyNNs
flanked without purine.
cPyNNs% was determined by calculating the% of probability of PyNNs
in total genome.
using a paired t-test. Despite some variations, results obtained
predicted model and actual experimental values showed that the
established models reliably predicted the D90 value. Therefore,
the predictive performance of the established model can be
considered acceptable. The applicability of the models was also
quantitatively evaluated by comparing the bias and accuracy
















The average mean deviation (E%) were used to determine
the fitting accuracy of data (Eq. 5). Where, ne is the number of
experimental data, VE is the experimental value and VP is the
predicted value.
In most cases, as shown in Table 4, the accuracy factor (AF)
values for the genomic model were close to 1.00, except for
Measles virus (0.83), Semliki forest virus (0.86). The bias factor
(BF) values for the predicted models were also close to 1.00,
ranging from 1.02 to 1.21 for the parameter studied. These
results clearly indicate that there was a good agreement between
predicted and observed D90 values. Ross et al. (2000) stated
that predictive models ideally would have an AF = BF = 1.00,
indicating a perfect model fit where the predicted and actual
response values are equal. However, typically, the AF of a fitted
model will increase by 0.10–0.15 units for each predictive variable
in the model (Ross et al., 2000). Genomic model, as in this study,
that forecasts a response may be expected to have AF and BF
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FIGURE 1 | Plot of genome size versus UV-C sensitivity of ssRNA viruses.
FIGURE 2 | Plot of PyNNFV versus UV-C sensitivity of ssRNA viruses. MSV, murine sarcoma virus; MS2, bacteriophage MS2; MML, moloney murine leukemia virus;
CSV, coxsackie virus; HPV, human parechovirus; PV, polio virus; CCV, canine calcivirus; FCV, feline calcivirus; HAV, hepatitis A virus; SV, sindbis virus; VEE,
venezuelan equine encephalitis virus; WEE, western equine encephalomyelitis virus; SFV, semliki forest virus; MV, measles virus; SCV, SARS-CoV-1.
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FIGURE 3 | Plot of model predicted D90 values versus Experimental D90 values.
TABLE 4 | Accuracy factors (AF) and Bias factors (BF) for D90 values in the
regression analysis.
Virus AF BF E (%)a
Bacteriophage MS2 1.02 1.02 2.18
Feline calicivirus 0.9 1.11 12.71
Coxsackievirus 1.03 1.03 2.48
Canine calicivirus 0.94 1.06 6.17
Semliki forest virus 0.86 1.16 18.18
Murine sarcoma 1.03 1.03 3.22
Measles virus 0.83 1.21 25.67
SARS-CoV-1 0.91 1.1 10.88
Murine norovirus 0.93 1.08 8.09
Moloney murine leukemia virus 0.96 1.04 4.33
Human parechovirus 1.13 1.13 10.09
Western equine encephalomyelitis virus 1.1 1.1 8.25
Venezuelan equine encephalitis virus 1.1 1.1 8.55
Sindbis virus 1.11 1.11 9.03
Hepatitis A virus 0.99 1.01 0.82
Polio virus 1.05 1.05 4.62
aAverage mean deviation.
values ranging from 0.83 to 1.21 or an equivalent percentage error
range of 0.82–25.67%.
Prediction of UV Sensitivity of Various
Corona Viruses and Human Noroviruses
Owing to good model fitting, the PyNNFV genomic model was
used to predict UV sensitivity of coronaviruses including SARS-
CoV-2 and different HuNoV genogroups. PyNNFV values of
target viruses were calculated from genomic sequences obtained
from the NCBI database. The UV sensitivities were predicted by
substituting PyNNFV value in Eq. 2. Table 5 shows PyNNFV
values and corresponding predicted D90 values of target viruses.
Predicted D90 of SARS-CoV-2 virus (21.5 J/m2) (Table 5) is
closer to the estimated D90 of SARS-CoV-1 (18 J/m2) from the
experimental study (Table 1). Kariwa et al. (2006) irradiated
2 mL of SARS-CoV-1 in 3-cm petri dishes without stirring UV-
C light at 134 µW/cm2 for 15 min, and observed reduction in
infectivity from 3.8 × 107 to 180 TCID50/mL with equivalent
to D90 value of 226 J/m2. In contrast, Darnell et al. (2004)
showed 4 log reduction of SARS-CoV-1 at UV-C exposure of
4016 µW/cm2 for 6 min which is equivalent to D90 value of
3610 J/m2. The authors conducted the experiment in a 24 well
plate containing 2 mL virus aliquots without mixing. These
two studies neither calculate the average irradiance nor provide
conditions for uniform UV-C dose distribution throughout
the test fluid and thereby reported higher values. The model
predicted D90 value of MERS-CoV (28.1 J/m2) that is found
to be higher than SARS-COV-2, whereas murine hepatitis
coronavirus (MHV) strains showed similar UV-C sensitivity (D90
values = 20.3 to 21 J/m2). For α- and γ-coronaviruses, the
predicted D90 values (17.8 to 18.3 J/m2) were lower than the
β-coronaviruses (Table 5). Saknimit et al. (1988) demonstrated
the efficiency of UV-C irradiation on the inactivation of
MHV and CCV coronaviruses using 15 W UV-C lamp at a
distance of 1 m and reported efficient UV-C inactivation after
15 min treatment. From this data, the estimated D90 values
for MHV and CCV (γ-coronavirus) were 17 and 15 J/m2,
respectively, and observed to be slightly lower (∼20%) than
the model predicted values (Table 5). Overall the results show
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TABLE 5 | Predicted of UV sensitivity with respect to dimerization values of target ssRNA viruses.
Virus NCBI Accession# Genome (bp) PyNNF values Predicted D90 Values (J/m2)
α-coronaviruses
Transmissible gastroenteritis virus KX499468.1 28614 0.000391 18.2
Canine coronavirus KP981644.1 29278 0.000379 18.0 (15.0)
Feline infectious peritonitis virus KC461237.1 29357 0.000393 18.3
Human coronavirus 229E KF514433.1 27165 0.000489 20.2
β-coronaviruses
SARS-CoV-2 MT192772.1 29891 0.000549 21.5
MERS-CoV MH734115.1 30033 0.000883 28.1
Murine hepatitis virus strain A59 MF618252.1 29947 0.000532 21.0 (17.0)
Murine hepatitis virus strain S GU593319.1 31147 0.000515 20.7 (17.0)
Murine coronavirus MHV-1 FJ647223.1 31386 0.000526 20.9 (17.0)
Rat coronavirus JF792617.1 31274 0.000494 20.3
Bat coronavirus BM48-31 NC_014470.1 29276 0.000603 22.5
Bat coronavirus HKU9-1 NC_009021.1 29114 0.000465 19.7
Bat coronavirus HKU4-1 NC_009019.1 30286 0.000580 22.0
Bat Hp-betacoronavirus NC_025217.1 31491 0.000691 24.2
SARS coronavirus A022 (Civet) AY686863.1 29499 0.0006401 23.2
SARS coronavirus B039 (Civet) AY686864.1 29525 0.0006402 23.2
γ-coronavirus
Avian infectious bronchitis virus NC_001451.1 27608 0.000371 17.8
Human noroviruses (non-enveloped)
Norovirus GI NC_001959.2 7654 0.002936 69.1
Norovirus GII KF712510.1 7509 0.003934 89.0
Norovirus GIV JF781268.1 7839 0.00336 77.6
Values in parenthesis denote estimated D90 values from experimental study (Saknimit et al., 1988).
that coronaviruses are highly sensitive to UV-C light than other
ssRNA viruses reported in Table 1. From the UV sensitivity
data obtained using the genomic model, it was observed that
UV doses ranging from 90 to 141 J/m2 are required for 5 log
reduction of human pathogenic coronaviruses (SARS-CoV-1,
MERS-CoV, 2019-nCoV). Here we demonstrate an example of
UV exposure using a low-pressure mercury lamp. If the UV-
C lamp source provides an average irradiance of 0.4 mW/cm2
or 4 W/m2 (under uniform dose distribution conditions), a
mere 35 s treatment is adequate to inactivate β-coronaviruses
(99.999% or 5 log reduction). Since the developed model relies
on total PyNNFV (not on specific gene sequences), slight
viral mutations should not cause significant variations in UV
sensitivity. For instance, if the PyNNFV value of SARS-CoV-
2 changes up to ±10%, the model predicted UV sensitivity
(D90 value) ranges from 20.4 to 22.6 J/m2 with the change of
just±2.6%.
The predicted D90 values of HuNoVs are 69.1, 89, and
77.6 J/m2 for genogroups, GI, GII, and GIV, respectively
(Table 5). The results revealed that the UV-C sensitivity of
GII was lower with higher predicted D90 value in comparison
to GI and GIV. To the best of our knowledge, limited
experimental data is currently available on UV-C sensitivity
of HuNoVs. Some research studies used RT-qPCR method to
estimate MNV survivors and validated with virus infectivity
assay (Wang and Tian, 2013; Rönnqvist et al., 2014; Walker
et al., 2019). The reported validation results showed that
the values obtained with RT-qPCR method are overestimated
compared to standard virus infectivity assays (Wang and
Tian, 2013; Rönnqvist et al., 2014; Walker et al., 2019). For
instance, Rönnqvist et al. (2014) reported 4-log reduction
of MNV at a UV dose of 60 mJ/cm2 with the infectivity
assay, whereas just 2-log decline of MNV and HuNoV RNA
levels was found at a UV dose of 150 mJ/cm2 by the RT-
qPCR method. The experimental D90 values of conservative
surrogates (MNV, echovirus and caliciviruses) obtained via
viability assay are reported to be in the range of 60–
100 J/m2 (Table 1).
Identification of Potential Surrogates for
UV-C Inactivation
Validation of the UV-C inactivation kinetics of specific pathogens
such as SARS-CoV-2 is not possible (without the use of
appropriate surrogates) because of the need for sophisticated
biosafety level (BSL)-3 containment, and to protect the
researchers, and the public from health risk in environmental
settings. For HuNoV, research on reproducible cultivable systems
that obtain high titers are still on-going. Hence, criteria for
the selection and application of surrogates are required to
ensure that the surrogates mimic the behavior of the SARS-
CoV-2 or HuNoVs under specific treatment conditions, while
ensuring safety of personnel and also decreasing labor, cost and
time. Also, surrogates are useful in process validation studies
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at scale up that can reduce the uncertainties linked with UV-C
dose measurement.
As seen from Table 5, the model predicted D90 value
(∼21.5 J/m2) of SARS-CoV-2 was comparable to MHV strains
(non-pathogenic to humans) of the β-coronavirus group
(∼21 J/m2), higher than α-coronaviruses (TGEV, CCV, and
FIPV) and γ-coronavirus (AIBV) (∼18 J/m2). Also, since both
SARS-CoV-2 and MHV are β-coronaviruses, MHV-strain A59
may show similar behavior under various culture conditions
making it a potential surrogate for SARS-CoV-2 for UV-C
inactivation kinetics and validation studies.
For HuNoVs, the predicted D90 values of all genogroups (69–
89 J/m2) were higher than D90 values of the reported caliciviruses
(60–67 J/m2) in our study, echoviruses (75 J/m2), except being
lower than MNV-1 (100 J/m2) (Tables 1, 5). Use of surrogates that
exhibit similar or slightly higher D90 values to target pathogens
can avoid the risk associated with improper inactivation, hence
our results indicate that MNV-1 is the better choice (though
conservative) to validate UV-C inactivation of all HuNoVs under
laboratory experimental setup conditions.
In conclusion, a predictive genomic-modeling method was
developed for estimating the UV sensitivity of SARS-CoV-2
and HuNoVs. Results of the model validation showed that
the developed model had acceptable predictive performance,
as assessed by mathematical and graphical model performance
indices. We predicted the D90 values by conducting extensive
genomic modeling. Although the parameters reported here may
suffice to estimate the UV sensitivity, experimental research
directed to address various knowledge gaps identified in this
study is required to maximize the accuracy of predicted models.
Additional parameters will be computed to the predictive model
as needed, including terms for the presence of chromophores or
UV absorbers and for possible UV scattering.
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